Heart Rhythm Clinical and Research Solutions, LLC
11
6
8
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 70/100
9.1%
1 terminated/withdrawn out of 11 trials
0.0%
-86.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Clinical and Healthcare Outcomes From Real-World Use in the United States of a Companion AI During AF Ablation
Role: collaborator
AI Powered Mapping Technology for Identifying Arrhythmias
Role: lead
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
Role: lead
Real-world Safety and Effectiveness Registry of Catheter Ablation of Paroxysmal Atrial Fibrillation as Initial Control Therapy With the Thermocool SmartTouch SF Catheter (A Sub-study of REAL AF Registry)
Role: lead
REView of ProcEdural FactoRs and Outcomes After Atrial Fibrillation Ablation With Active Esophageal COOLing: A Sub-Study of the REAL AF Registry
Role: lead
A Registry Based Collaborative to Measure Efficiency, Effectiveness, and Safety of Farapulse PFA Technology for AF
Role: lead
Safety and Efficacy of Workflows of High Volume Single Operators in a LAAO Device Implant Procedural Day
Role: lead
Concomitant LAAC/AF Ablation (Watchman FLX Pro)
Role: lead
Real-world Experience of Catheter Ablation for the Treatment of Paroxysmal and Persistent Atrial Fibrillation
Role: lead
Amplify EP Registry
Role: lead
Real-World Evidence Registry to Assess Outcomes of Catheter Ablation for Atrial Fibrillation (DYNAMIC AF Registry)
Role: lead
All 11 trials loaded